Search

Your search keyword '"Spinelli MA"' showing total 92 results

Search Constraints

Start Over You searched for: Author "Spinelli MA" Remove constraint Author: "Spinelli MA"
92 results on '"Spinelli MA"'

Search Results

1. Clinical and radiological evaluation of fracture union in pathologic fractures after closed intramedullary nailing and adjuvant radiotherapy: A retrospective study

2. The clinical outcomes after surgical treatment of mass lesions causing sciatica - a single-center retrospective study

3. Calcium Looping technology demonstration in industrial environment: the CLEANKER project and status of the CLEANKER pilot plant

4. Nutritional conditions indicators in Polonoroeste Area: IV - Food inquiry in families in 6 cities of Polonoroeste/MT Area, 1983

5. Indicadores das condições nutricionais na região do Polonoroeste: III. Estudo clínico nutricional

6. Indicadores das condições nutricionais na região do polonoroeste: II. Estudo antropométrico - 1983

7. Saúde da família no Estado de Mato Grosso, Brasil: perfis e julgamentos dos médicos e enfermeiros

8. Respiratory syncytial virus infection in infants and correlation with meteorological factors and air pollutants

9. A case of parosteal osteosarcoma with a rare complication of myositis ossificans

10. Synovial hemangiohamartoma presenting as knee pain, swelling and a soft tissue mass: a case report

11. The Impact of Adherence Counselling Incorporating a Point of Care Urine Tenofovir Assay on Virologic Suppression among Individuals Failing Tenofovir-Lamivudine-Dolutegravir: A Pre - Post intervention Study.

13. High Retention and Adherence with Rapid Long-Acting Injectable PrEP Implementation in an Urban Safety-Net Clinic Population.

14. Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young users.

15. Prevalence and Correlates of SARS-CoV-2 Vaccine Uptake and Hesitancy Among People With HIV Across the United States.

16. Impact of the Coronavirus Disease 2019 Pandemic on Substance Use Disorder Risk Among People Living With Human Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: An Interrupted Time Series Analysis.

17. Impact of a point-of-care urine tenofovir assay on adherence to HIV pre-exposure prophylaxis among women in Kenya: a randomised pilot trial.

18. Plasma-based antigen persistence in the post-acute phase of COVID-19.

19. Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis.

20. Pandemic expertise: qualitative findings on the experiences of living with HIV during the COVID-19 pandemic.

21. Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection.

22. Urine point-of-care tenofovir test demonstrates strong predictive clinical and research utility.

23. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial.

24. Adherence determination using urine-tenofovir point-of-care testing and pharmacy refill records: A cross-sectional study.

25. Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID With Exercise Capacity and Chronotropic Incompetence Among People With HIV.

26. Comparison of combined substrate-based mapping techniques to identify critical sites for ventricular tachycardia ablation.

27. Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure.

28. Pragmatic randomized trial of a pre-visit intervention to improve the quality of telemedicine visits for vulnerable patients living with HIV.

29. Chronic viral coinfections differentially affect the likelihood of developing long COVID.

30. COVID-19 Outcomes and Risk Factors Among People Living with HIV.

31. Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery.

32. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.

33. Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study.

34. Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis.

35. Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID.

36. Promises and challenges: cabotegravir for preexposure prophylaxis.

37. Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement.

38. SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV.

39. Sensitivity and Specificity of the National Death Index for Multiple Causes of Death in People With HIV.

40. Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity.

41. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.

42. SARS-CoV-2 vaccination in people with HIV.

44. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.

46. Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide-based ART.

48. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.

49. Use of Drug-level Testing and Single-genome Sequencing to Unravel a Case of Human Immunodeficiency Virus Seroconversion on Pre-exposure Prophylaxis.

50. Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing.

Catalog

Books, media, physical & digital resources